{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:00:31Z","timestamp":1763766031139},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/med.0b013e32834c3c0b","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T16:12:44Z","timestamp":1377879164000},"page":"352-358","source":"Crossref","is-referenced-by-count":11,"title":["Paget's disease of bone"],"prefix":"10.1097","volume":"18","author":[{"given":"Dorit","family":"Naot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20211004","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/jbmr.64","article-title":"Archaeological skeletons support a northwest European origin for Pagets disease of bone.","volume":"25","author":"Mays","year":"2010","journal-title":"J Bone Miner Res"},{"key":"R2-4-20211004","first-page":"1232","article-title":"Pagets disease of bone: becoming a rarity Rheumatology (Oxford","volume":"48","author":"Bastin","year":"2009","journal-title":")"},{"key":"R3-4-20211004","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1586\/eem.09.43","article-title":"Pagets disease of bone.","volume":"4","author":"Matthews","year":"2009","journal-title":"Expert Rev Endocrinol Metab"},{"key":"R4-4-20211004","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1093\/hmg\/11.22.2735","article-title":"Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Pagets disease.","volume":"11","author":"Hocking","year":"2002","journal-title":"Hum Mol Genet"},{"key":"R5-4-20211004","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/340731","article-title":"Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1p62) in Paget disease of bone.","volume":"70","author":"Laurin","year":"2002","journal-title":"Am J Hum Genet"},{"key":"R6-4-20211004","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1749-6632.2009.05214.x","article-title":"Insights into the pathogenesis of Pagets disease.","volume":"1192","author":"Roodman","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"R7-4-20211004","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/BOR.0b013e32833af61e","article-title":"Pagets disease of bone: theres more than the affected skeletal - a clinical review and suggestions for the clinical practice.","volume":"22","author":"Falchetti","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"R8-4-20211004","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00296-008-0814-2","article-title":"Pagets disease of the bone: a review.","volume":"29","author":"McNeill","year":"2009","journal-title":"Rheumatol Int"},{"key":"R9-4-20211004","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jbspin.2010.07.010","article-title":"Genetics of bone diseases: Pagets disease, fibrous dysplasia, osteopetrosis, and osteogenesis imperfecta.","volume":"78","author":"Michou","year":"2010","journal-title":"Joint Bone Spine"},{"key":"R10-4-20211004","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bone.2010.09.002","article-title":"Bisphosphonates in Pagets disease.","volume":"49","author":"Reid","year":"2010","journal-title":"Bone"},{"key":"R11-4-20211004","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/jbmr.438","article-title":"A single infusion of zoledronic acid produces sustained remissions in Pagets disease - data to 6.5 years.","volume":"26","author":"Reid","year":"2011","journal-title":"J Bone Miner Res"},{"key":"R12-4-20211004","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1359\/jbmr.061001","article-title":"Long-term control of bone turnover in Pagets disease with zoledronic acid and risedronate.","volume":"22","author":"Hosking","year":"2007","journal-title":"J Bone Miner Res"},{"key":"R13-4-20211004","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJMoa044241","article-title":"Comparison of a single infusion of zoledronic acid with risedronate for Pagets disease.","volume":"353","author":"Reid","year":"2005","journal-title":"N Engl J Med"},{"key":"R14-4-20211004","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1359\/jbmr.090709","article-title":"Randomized trial of intensive bisphosphonate treatment versus symptomatic management in Pagets disease of bone.","volume":"25","author":"Langston","year":"2010","journal-title":"J Bone Miner Res"},{"key":"R15-4-20211004","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/jbmr.97","article-title":"The PRISM trial: reply to the editor.","volume":"25","author":"Ralston","year":"2010","journal-title":"J Bone Miner Res"},{"key":"R16-4-20211004","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrrheum.2009.230","article-title":"Metabolic bone diseases: treating Paget disease - when matters more than how.","volume":"5","author":"Brown","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"R18-4-20211004","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bone.2010.11.004","article-title":"Novel SQSTM1 mutations in patients with Pagets disease of bone in an unrelated multiethnic American population.","volume":"48","author":"Michou","year":"2011","journal-title":"Bone"},{"key":"R19-4-20211004","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1359\/jbmr.090214","article-title":"Sequestosome 1 mutations in Pagets disease of bone in Australia: prevalence, genotypephenotype correlation, and a novel non-UBA domain mutation (P364S) associated with increased NF-kappaB signaling without loss of ubiquitin binding.","volume":"24","author":"Rea","year":"2009","journal-title":"J Bone Miner Res"},{"key":"R20-4-20211004","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/BF03346640","article-title":"Epidemiological, clinical, and genetic characteristics of Pagets disease of bone in a rural area of Calabria, Southern Italy.","volume":"33","author":"Rendina","year":"2010","journal-title":"J Endocrinol Invest"},{"key":"R21-4-20211004","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00223-011-9514-0","article-title":"Familial Pagets disease and SQSTM1 mutations in New Zealand.","volume":"89","author":"Cundy","year":"2011","journal-title":"Calcif Tissue Int"},{"key":"R22-4-20211004","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/jbmr.31","article-title":"SQSTM1 gene analysis and gene-environment interaction in Pagets disease of bone.","volume":"25","author":"Gennari","year":"2010","journal-title":"J Bone Miner Res"},{"key":"R23-4-20211004","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/jbmr.132","article-title":"Mutations of SQSTM1 are associated with severity and clinical outcome in paget disease of bone.","volume":"25","author":"Visconti","year":"2010","journal-title":"J Bone Miner Res"},{"key":"R24-4-20211004","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1359\/jbmr.061204","article-title":"Delayed development of Pagets disease in offspring inheriting SQSTM1 mutations.","volume":"22","author":"Bolland","year":"2007","journal-title":"J Bone Miner Res"},{"key":"R25-4-20211004","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1210\/jc.2008-1140","article-title":"Absence of somatic SQSTM1 mutations in Pagets disease of bone.","volume":"94","author":"Matthews","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-4-20211004","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1359\/jbmr.081105","article-title":"Somatic mutations in SQSTM1 detected in affected tissues from patients with sporadic Pagets disease of bone.","volume":"24","author":"Merchant","year":"2009","journal-title":"J Bone Miner Res"},{"key":"R27-4-20211004","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-2362.2010.02312.x","article-title":"Genetic aspects of the Pagets disease of bone: concerns on the introduction of DNA-based tests in the clinical practice. Advantages and disadvantages of its application.","volume":"40","author":"Falchetti","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"R28-4-20211004","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bone.2010.09.021","article-title":"Pagets disease of bone: the skeletal distribution, complications and quality of life as perceived by patients.","volume":"48","author":"Seton","year":"2011","journal-title":"Bone"},{"key":"R29-4-20211004","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cmet.2010.12.002","article-title":"Contributions of the measles virus nucleocapsid gene and the SQSTM1p62(P392L) mutation to Pagets disease.","volume":"13","author":"Kurihara","year":"2011","journal-title":"Cell Metab"},{"key":"R30-4-20211004","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1359\/jbmr.070333","article-title":"Identification of sex-specific associations between polymorphisms of the osteoprotegerin gene, TNFRSF11B, and Pagets disease of bone.","volume":"22","author":"Beyens","year":"2007","journal-title":"J Bone Miner Res"},{"key":"R31-4-20211004","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1359\/JBMR.040602","article-title":"Susceptibility to Pagets disease of bone is influenced by a common polymorphic variant of osteoprotegerin.","volume":"19","author":"Daroszewska","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R32-4-20211004","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/ng.562","article-title":"Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Pagets disease of bone.","volume":"42","author":"Albagha","year":"2010","journal-title":"Nat Genet"},{"key":"R33-4-20211004","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1002\/jbmr.162","article-title":"Genetic variation in the TNFRSF11A gene encoding RANK is associated with susceptibility to Pagets disease of bone.","volume":"25","author":"Chung","year":"2010","journal-title":"J Bone Miner Res"},{"key":"R34-4-20211004","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00439-010-0888-2","article-title":"The majority of the genetic risk for Pagets disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genes.","volume":"128","author":"Chung","year":"2010","journal-title":"Hum Genet"},{"key":"R35-4-20211004","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ng.845","article-title":"Genome-wide association identifies three new susceptibility loci for Pagets disease of bone.","volume":"43","author":"Albagha","year":"2011","journal-title":"Nat Genet"},{"key":"R36-4-20211004","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ymgme.2011.03.021","article-title":"Indications for a genetic association of a VCP polymorphism with the pathogenesis of sporadic Pagets disease of bone, but not for TNFSF11 (RANKL) and IL-6 polymorphisms.","volume":"103","author":"Chung","year":"2011","journal-title":"Mol Genet Metab"},{"key":"R37-4-20211004","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cyto.2010.07.008","article-title":"Pagets disease of bone is not associated with common polymorphisms in interleukin-6, interleukin-8 and tumor necrosis factor alpha genes.","volume":"52","author":"Corral-Gudino","year":"2010","journal-title":"Cytokine"},{"key":"R38-4-20211004","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1359\/jbmr.061108","article-title":"Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Pagets disease of bone.","volume":"22","author":"Naot","year":"2007","journal-title":"J Bone Miner Res"},{"key":"R39-4-20211004","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.clinbiochem.2009.04.007","article-title":"Increased circulating Dickkopf-1 in Pagets disease of bone.","volume":"42","author":"Marshall","year":"2009","journal-title":"Clin Biochem"},{"key":"R40-4-20211004","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.bone.2009.11.012","article-title":"Gene expression profile in osteoclasts from patients with Pagets disease of bone.","volume":"46","author":"Michou","year":"2010","journal-title":"Bone"},{"key":"R41-4-20211004","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1093\/hmg\/ddq157","article-title":"Inclusion body myopathy, Pagets disease of the bone and fronto-temporal dementia: a disorder of autophagy.","volume":"19","author":"Ju","year":"2010","journal-title":"Hum Mol Genet"},{"key":"R42-4-20211004","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/hmg\/ddr172","article-title":"A point mutation in the ubiquitin associated domain of SQSMT1 is sufficient to cause a Pagets disease like disorder in mice.","volume":"20","author":"Daroszewska","year":"2011","journal-title":"Hum Mol Genet"},{"key":"R43-4-20211004","doi-asserted-by":"crossref","first-page":"e13183","DOI":"10.1371\/journal.pone.0013183","article-title":"VCP associated inclusion body myopathy and paget disease of bone knock-in mouse model exhibits tissue pathology typical of human disease.","volume":"5","author":"Badadani","year":"2010","journal-title":"PLoS One"},{"key":"R44-4-20211004","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1093\/hmg\/ddq050","article-title":"Transgenic mice expressing mutant forms VCPp97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone.","volume":"19","author":"Custer","year":"2010","journal-title":"Hum Mol Genet"},{"key":"R45-4-20211004","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1210\/me.2009-0066","article-title":"The p62 P392L mutation linked to Pagets disease induces activation of human osteoclasts.","volume":"23","author":"Chamoux","year":"2009","journal-title":"Mol Endocrinol"},{"key":"R46-4-20211004","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1359\/jbmr.060405","article-title":"A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Pagets disease of bone with a severe phenotype.","volume":"21","author":"Rea","year":"2006","journal-title":"J Bone Miner Res"},{"key":"R47-4-20211004","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2353\/ajpath.2006.050960","article-title":"p62 Ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Pagets disease of bone.","volume":"169","author":"Yip","year":"2006","journal-title":"Am J Pathol"},{"key":"R48-4-20211004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399407000464","article-title":"The molecular pathogenesis of Pagets disease of bone.","volume":"9","author":"Layfield","year":"2007","journal-title":"Expert Rev Mol Med"},{"key":"R49-4-20211004","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1021\/bi200079n","article-title":"Impact of p62SQSTM1 UBA domains mutations linked to Pagets disease of bone on ubiquitin recognition.","volume":"50","author":"Garner","year":"2011","journal-title":"Biochemistry"},{"key":"R50-4-20211004","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jmb.2009.11.032","article-title":"Dimerisation of the UBA domain of p62 inhibits ubiquitin binding and regulates NF-kappaB signalling.","volume":"396","author":"Long","year":"2010","journal-title":"J Mol Biol"},{"key":"R51-4-20211004","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1359\/JBMR.041205","article-title":"Loss of ubiquitin-binding associated with Pagets disease of bone p62 (SQSTM1) mutations.","volume":"20","author":"Cavey","year":"2005","journal-title":"J Bone Miner Res"},{"key":"R52-4-20211004","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00223-005-1299-6","article-title":"Loss of ubiquitin binding is a unifying mechanism by which mutations of SQSTM1 cause Pagets disease of bone.","volume":"78","author":"Cavey","year":"2006","journal-title":"Calcif Tissue Int"},{"key":"R53-4-20211004","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1359\/jbmr.081204","article-title":"Characterization of a non-UBA domain missense mutation of sequestosome 1 (SQSTM1) in Pagets disease of bone.","volume":"24","author":"Najat","year":"2009","journal-title":"J Bone Miner Res"},{"key":"R54-4-20211004","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.cell.2010.11.012","article-title":"Ubiquitin: same molecule, different degradation pathways.","volume":"143","author":"Clague","year":"2010","journal-title":"Cell"},{"key":"R55-4-20211004","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.febslet.2010.03.018","article-title":"Mutant p62SQSTM1 UBA domains linked to Pagets disease of bone differ in their abilities to function as stabilization signals.","volume":"584","author":"Heinen","year":"2010","journal-title":"FEBS Lett"},{"key":"R56-4-20211004","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bbrc.2010.10.076","article-title":"Functional interaction between sequestosome-1p62 and autophagy-linked FYVE-containing protein WDFY3 in human osteoclasts.","volume":"402","author":"Hocking","year":"2010","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Current Opinion in Endocrinology, Diabetes & Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01266029-201112000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T01:56:36Z","timestamp":1633312596000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01266029-201112000-00004"}},"subtitle":["an update"],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/med.0b013e32834c3c0b","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}